The Silent Epidemic: Uncovering Hidden Beta Cell Loss Across Diseases

Beta cell loss starts long before diabetes is diagnosed—but its impact extends far beyond blood sugar regulation. Until now, there was no way to measure it in real time. Our groundbreaking test quantifies beta cell dysfunction as it happens, enabling earlier intervention and more precise treatment strategies. Emerging research reveals its critical role in diabetes, pancreatic cancer, obesity, Alzheimer's disease, and other metabolic and autoimmune disorders, reshaping our understanding of disease progression and opening new pathways for prevention and care.